Document Search

Notice of adoption to text of regulations Title 27, California Code of Regulations amendment to section 25805 Maximum Allowable Dose Level (MADL) for Avermectin B1

Announcement of the October 12th and 13th2011 CIC meeting and hazard ID materials for fluoride and its salts, and tris(1,3-Dichloro-2-Propyl) phosphate.  Both will be considered for listing at the October 2011 meeting.

The proposed NSRL for 4-MEI has been changed from 16 to to 29 micrograms per day.

Proposal to add a NSRL for imazalil of 11ug/day.

The PHG for hexavalent chromium is established at 0.02 parts per billion (ppb). The health-protective level is based on avoidance of potential carcinogenic effects.

Notice of proposed rulemaking Title 27, California Code of Regulations proposed amendment of Section 25703(A)(6) quantitative risk assessment to modify the calculation used to convert estimates of animal cancer potency to estimates of human cancer potency. 

The PHG for chromium 6 reflects research documenting that young children and other sensitive subpopulations are more susceptible than the general population to health risks from exposure to carcinogens. The final PHG for hexavalent chromium, also known as chromium 6, is set at 0.02 parts per billion (ppb).

This July 2011 notice announces the beginning of a 60-day public comment period on 39 chemicals which will be discussed at the October 2011 meeting of the Proposition 65 Carcinogen Identification Committee (CIC).

A Maximum Allowable Dose Level (MADL) for chromium (hexavalent compounds) was established.  The amendment will become effective July 29, 2011.

Agenda, meeting summary and detailed information for the July 11 and 12 DART IC.